Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01651702
Other study ID # 0067-12-RMC
Secondary ID
Status Withdrawn
Phase N/A
First received July 23, 2012
Last updated April 12, 2017
Start date July 2015
Est. completion date October 2016

Study information

Verified date April 2017
Source Rabin Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Three dimensional anatomical mapping is an established method facilitating ablation of cardiac arrhythmias. The most commonly used systems are CARTO® System (Biosense Webster, Inc., Diamond Bar, CA, USA) and EnSite NavX™ (St. Jude Medical, Inc., St. Paul, MN, USA). These two systems has been compared in only a few studies. Recent technical advances resulted in the development of new versions of both systems. To the best of the investigators knowledge no studies have been performed for direct comparison of the newer versions of these two systems. The aim of the study to compare two systems for the use in the ablation of complex arrhythmias.


Description:

Background:

Three dimensional anatomical mapping is an established method facilitating ablation of cardiac arrhythmias. It is nowadays an excepted method especially for complex arrhythmias such as atrial fibrillation and ventricular tachycardia.

The most commonly used systems are CARTO® System (Biosense Webster, Inc., Diamond Bar, CA, USA) and EnSite NavX™ (St. Jude Medical, Inc., St. Paul, MN, USA). These mapping systems have helped to decrease procedural complexity, procedure time, and improve safety. The EnSite NavX system uses impedance measurements between the individual catheter electrodes and the patches placed on the patient's chest and abdomen. The CARTO system utilizes magnetic location technology to provide accurate visualization of the magnet sensor-equipped catheter tip.

These two systems has been compared in only a few studies. Different results have been found in simple ablations versus more complex ablation of atrial fibrillation. Recent technical advances resulted in the development of new versions of both systems. Carto Express version allows quicker mapping and reconstruction of heart cavities and great vessels geometry as compared to previous versions of Carto XP. EnSite Velocity system incorporates more precise catheter visualization, and allows quicker mapping as compared to previous version of EnSite.

To the best of the investigators knowledge no studies have been performed for direct comparison of the newer versions of these two systems.

Study design Prospective single-center non-randomized open label comparison study. Primary objective Comparison of Carto Express system vs. EnSite Velocity system for ablation of complex arrhythmias.

End points:

1. Procedure duration.

2. Fluoroscopy time

3. Procedure success -will be measured in terms of the 1-year recurrent arrhythmia rate Study population Patients planned for ablation of complex arrhythmia.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 2016
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. Age 18- 80.

2. Ability to sign informed consent.

3. History of one of the following arrhythmias requiring the use of 3D electroanatomical mapping:

- Symptomatic paroxysmal or persistent atrial fibrillation with failed treatment of at least two anti-arrhythmic drugs.

- Ischemic ventricular tachycardia necessitating ablation as per decision of electrophysiologist.

- Symptomatic atrial tachycardia after failed medical treatment.

- Symptomatic idiopathic ventricular tachycardia.

Exclusion Criteria:

1. Unstable patients not allowing performing procedure more than 2 hours

2. Patients planned for one of the two systems compared for whatever reason Ex. procedure planned with NAVX system Array Balloon).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Carto
Group of patients where Carto Express system will be used for electroanatomical mapping.
Ensite
Group of patients where Ensite Velocity system will be used for electroanatomical mapping.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Rabin Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary Procedure duration Average procedure duration (needle to catheters withdrawal) Procedure duration - average expected 2.5 hours
Secondary Fluoroscopy time Average fluro time in each of groups. Procedures will be evaluated for the fluoro time, expected average 30 min
Secondary Procedure success Recurrency of the arrhythmia assessed by blinded electrophysiologist Patients will be followed for one year for recurrency of arrhythmia
See also
  Status Clinical Trial Phase
Recruiting NCT03289429 - Antiarrhythmic and Cardioprotective Effects of Atorvastatin Versus Magnesium Sulfate in Cardiac Valve Replacement Surgery Phase 4
Unknown status NCT01834872 - Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System as Compared With Manual Ablation Phase 4
Withdrawn NCT01026961 - Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers Phase 1/Phase 2
Not yet recruiting NCT05994755 - Association Between Cardiac ARRHYTHMIAs and Glycemic Variability in Patient With Type 2 Diabetes Monitored Through FREEstyle Libre and Bluetooth Technology.
Not yet recruiting NCT06039176 - Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Completed NCT02598258 - Hemodynamic Effects of Dry Sauna Followed by Cold Water Immersion in Healthy Subjects N/A
Withdrawn NCT02575534 - Acute Mechanical Response to Anti-arrhythmic Drug Therapy N/A
Withdrawn NCT00580255 - Comparison Study of BNP and Thoracic Impedance Measurements on Arrhythmias N/A
Completed NCT00751738 - Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs) Phase 3
Completed NCT02629445 - HIPACE High Frequency Low Energy Pacing to Terminate Fast Ventricular Arrythmias N/A
Recruiting NCT04563091 - Potassium Kinetic During and After Hemodialysis and Potassium Profiling to Prevent Arrhythmias N/A
Completed NCT00589849 - T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy N/A
Active, not recruiting NCT03121183 - Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers N/A
Completed NCT02110004 - Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man Phase 1
Completed NCT02045043 - Genetic Risk Assessment of Defibrillator Events N/A
Recruiting NCT01717469 - Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias Phase 4
Completed NCT00919568 - Monitoring Arrhythmia Patients (IMPACT) N/A
Terminated NCT00124891 - Study Evaluating GAP-486 in Non-sustained Ventricular Tachycardia Phase 2
Completed NCT02565069 - Identification for the Treatment of Complex Arrhythmias Phase 4
Completed NCT03110146 - EnSite Precision 2.1 Feasibility Study